APPLICABILITY OF DIFFERENT TYPES OF MODELS IN HEALTH AND DISEASE

被引：5

作者：

BALANT, L ^{[1
]}

机构：

[1] ZYMA SA,CH-1260 NYON,SWITZERLAND

来源：

DRUG METABOLISM REVIEWS | 1984年 / 15卷 / 1-2期

关键词：

D O I：

10.3109/03602538409015058

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：75 / 102

页数：28

共 23 条

[1]

ABELE R, 1978, PHARM ACTA HELV, V53, P253

[2]

BALANT L, 1977, PHARM ACTA HELV, V52, P89

[3]

BALANT L, 1980, Nephrologie, V1, P177

[4] SIMULTANEOUS TUBULAR EXCRETION AND REABSORPTION OF PINDOLOL IN MAN [J].

BALANT, L ;

MUIR, K ;

DAYER, P ;

GORGIA, A ;

EBERLIN, JL ;

ESTREICHER, J ;

FABRE, J .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 21 (01) :65-72

[5] INFLUENCE OF RENAL-FAILURE ON THE HEPATIC-CLEARANCE OF BUFURALOL IN MAN [J].

BALANT, L ;

FRANCIS, RJ ;

TOZER, TN ;

MARMY, A ;

TSCHOPP, JM ;

FABRE, J .

JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1980, 8 (05) :421-438

[6]

BALANT L, 1980, Nephrologie, V1, P172

[7]

BALANT L, 1978, PHARM ACTA HELV, V53, P307

[8] DO WE NEED A 3-COMPARTMENT MODEL FOR THE PREDICTION OF DIGOXIN BLOOD-LEVELS ON MULTIPLE DOSING [J].

BALANT, L ;

HUNT, CA .

JOURNAL OF CLINICAL AND HOSPITAL PHARMACY, 1980, 5 (01) :31-34

[9] THE PHARMACOKINETIC REQUIREMENTS FOR THE PREDICTION OF DIGOXIN SERUM LEVELS FOLLOWING CHRONIC DOSING [J].

BALANT, L ;

BAUER, F ;

HUNT, CA ;

ESCHEICHER, J ;

HUMAIR, L .

JOURNAL OF CLINICAL AND HOSPITAL PHARMACY, 1980, 5 (01) :35-42

[10]

BALANT L, 1976, SCHWEIZ MED WSCHR, V106, P1403

← 1 2 3 →